As of 2024-12-15, the Relative Valuation of Molecular Partners AG (MOLN.SW) is (18.55) CHF. This relative valuation is based on P/E multiples. With the latest stock price at 4.96 CHF, the upside of Molecular Partners AG based on Relative Valuation is -474.0%.
The range of the Relative Valuation is (19.45) - (20.50) CHF.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 15.2x | 14.7x |
| Forward P/E multiples | 4.6x - 10.9x | 5.1x |
| Fair Price | (19.45) - (20.50) | (18.55) |
| Upside | -492.1% - -513.2% | -474.0% |
| Date | P/E |
| 2024-12-12 | -2.65 |
| 2024-12-11 | -2.61 |
| 2024-12-10 | -2.70 |
| 2024-12-09 | -2.66 |
| 2024-12-06 | -2.70 |
| 2024-12-05 | -2.66 |
| 2024-12-04 | -2.78 |
| 2024-12-03 | -2.72 |
| 2024-12-02 | -2.57 |
| 2024-11-29 | -2.78 |
| 2024-11-28 | -2.80 |
| 2024-11-27 | -2.78 |
| 2024-11-26 | -2.78 |
| 2024-11-25 | -2.72 |
| 2024-11-22 | -2.59 |
| 2024-11-21 | -2.57 |
| 2024-11-20 | -2.56 |
| 2024-11-19 | -2.62 |
| 2024-11-18 | -2.75 |
| 2024-11-15 | -2.59 |
| 2024-11-14 | -2.59 |
| 2024-11-13 | -2.78 |
| 2024-11-12 | -2.72 |
| 2024-11-11 | -2.88 |
| 2024-11-08 | -2.95 |
| 2024-11-07 | -2.78 |
| 2024-11-06 | -2.96 |
| 2024-11-05 | -2.56 |
| 2024-11-04 | -2.70 |
| 2024-11-01 | -2.88 |
| 2024-10-31 | -2.73 |
| 2024-10-30 | -2.91 |
| 2024-10-29 | -2.99 |
| 2024-10-28 | -3.09 |
| 2024-10-25 | -3.06 |
| 2024-10-24 | -2.95 |
| 2024-10-23 | -2.70 |
| 2024-10-22 | -3.10 |
| 2024-10-21 | -3.04 |
| 2024-10-18 | -2.38 |
| 2024-10-17 | -2.26 |
| 2024-10-16 | -2.27 |
| 2024-10-15 | -2.24 |
| 2024-10-14 | -2.29 |
| 2024-10-11 | -2.19 |
| 2024-10-10 | -2.23 |
| 2024-10-09 | -2.23 |
| 2024-10-08 | -2.31 |
| 2024-10-07 | -2.19 |
| 2024-10-04 | -2.21 |